Bristol-Myers Squibb Co - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMY New York 2834 https://www.bms.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bristol-Myers Squibb Co

APPH, BMY, EAR, HYZN SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set - Oct 16th, 2021 2:50 am
Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know - Oct 15th, 2021 9:45 pm
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick - Oct 15th, 2021 2:00 pm
Prothena (PRTA) Riding High on Alzheimer's Disease Pipeline - Oct 15th, 2021 1:34 pm
James Morrow’s Callodine Capital Portfolio: Top 10 Picks - Oct 15th, 2021 1:29 pm
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia (ozanimod) as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis - Oct 15th, 2021 10:59 am
APPH, BMY, WDH SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set - Oct 15th, 2021 2:30 am
Team BMS Moves for Minutes to Benefit Special Olympics - Oct 14th, 2021 1:01 pm
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, HNST, PYPL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits - Oct 14th, 2021 2:36 am
Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know - Oct 13th, 2021 9:50 pm
Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis - Oct 13th, 2021 10:59 am
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of APPH, BMY, EAR and HYZN - Oct 13th, 2021 2:35 am
BMY, EAR, SLQT SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set - Oct 12th, 2021 8:30 pm
bluebird (BLUE) Gives Details on Oncology Business Spinoff - Oct 12th, 2021 1:14 pm
The Zacks Analyst Blog Highlights: NextEra Energy, Raytheon, Bristol-Myers Squibb, Williams Companies and Occidental Petroleum - Oct 12th, 2021 12:06 pm
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ANVS, BMY, HNST, PYPL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits - Oct 12th, 2021 2:47 am
OLA and PRIDE Alliance PBRGs teamed up to host an empowering storytelling forum - Oct 11th, 2021 7:51 pm
Top Stock Reports for NextEra, Raytheon & Bristol-Myers - Oct 11th, 2021 7:48 pm
INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of BMY, EAR Investors, Lead Plaintiff Deadlines Set - Oct 11th, 2021 7:15 pm
11 Best Dividend Aristocrats with over 3% Yield - Oct 9th, 2021 2:23 pm